** Shares of Neuland Laboratories NEUL.NS down as much as
14.7% to 6,088.10 rupees, their biggest intraday pct loss since
March 2020
** Pharmaceutical firm on Friday reported a 20% Y/Y fall in
its March-qtr consolidated profit to 675.6 mln rupees ($8.1
mln)
** Revenue from operations fell 5.4% Y/Y
** EBITDA margin contracts to 28.7% from 30.8% a year
earlier
** More than 80,000 shares change hands by 10:23 a.m. IST,
2.4x their 30-day avg volume
** Stock on track for a third straight session of losses, if
trend holds
** Including session's move, stock is up 16.2% YTD
($1 = 83.5150 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))